ABBV
AbbVie Inc.
Stock
$263.29−2.99 (−1.12%)Close Sep 29, 2026
| Capital expenditures (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $1.3B | +24.2% | 8.8% | 8.6% |
| Capital expenditures (TTM) | $1.3B |
|---|---|
| YoY | +24.2% |
| 5-year CAGR | 8.8% |
| 10-year CAGR | 8.6% |
Capital expenditures
| Period | Capex | YoY |
|---|---|---|
| 2025 | $1.2B | +24.6% |
| 2024 | $974M | +25.4% |
| 2023 | $777M | +11.8% |
| 2022 | $695M | −11.7% |
| 2021 | $787M | −1.4% |
| 2020 | $798M | +44.6% |
| 2019 | $552M | −13.5% |
| 2018 | $638M | +20.6% |
| 2017 | $529M | +10.4% |
| 2016 | $479M | −10.0% |
| 2015 | $532M | −13.1% |
| 2014 | $612M | +24.6% |
| 2013 | $491M | +47.4% |
| 2012 | $333M | −6.5% |
| 2011 | $356M | — |